DXCM
DexCom Inc
89.50$
+0.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 36.1% | 36.5% | 39.0% | 37.6% | 40.3% | 41.1% | 43.1% | 40.5% | 39.5% | 37.1% | 37.1% | 36.6% | 37.5% | |
| 63.9% | 63.5% | 61.0% | 62.4% | 59.7% | 58.9% | 56.9% | 59.5% | 60.5% | 62.9% | 62.9% | 63.4% | 62.5% | |
| 13.5% | 13.2% | 15.4% | 13.5% | 13.6% | 12.5% | 14.0% | 12.8% | 13.0% | 11.8% | 12.2% | 11.7% | 12.2% | |
| 29.2% | 12.4% | 34.7% | 33.1% | 30.8% | 12.0% | 29.9% | 28.3% | 27.4% | 25.5% | 29.3% | 27.4% | 27.4% | |
| 42.9% | 42.5% | 50.0% | 46.7% | 44.4% | 41.9% | 43.9% | 41.2% | 40.4% | 37.3% | 41.5% | 39.1% | 39.5% | |
| 21.1% | 21.0% | 11.0% | 15.7% | 15.3% | 17.0% | 12.9% | 18.4% | 20.1% | 25.6% | 21.4% | 24.3% | 22.9% | |
| 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.4% | 0.5% | 0.4% | 0.4% | 0.3% | 0.3% | 0.2% | 0.3% | |
| 24.7% | 23.8% | 14.4% | 18.7% | 17.8% | 19.0% | 14.9% | 20.8% | 29.1% | 27.0% | 22.6% | 24.3% | 25.8% | |
| 12.3% | -1.0% | -1.5% | 4.4% | 4.3% | 5.4% | 4.7% | 5.3% | 5.7% | 5.8% | 5.9% | 5.2% | 5.6% | |
| 12.4% | 24.8% | 15.9% | 14.3% | 13.5% | 13.6% | 10.2% | 15.5% | 23.5% | 21.2% | 16.7% | 19.0% | 20.1% | |
| 30.1% | 29.3% | 20.6% | 24.4% | 23.9% | 24.6% | 21.1% | 26.7% | 34.8% | 32.6% | 28.5% | 29.7% | 31.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.